Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anna Kandili"'
Autor:
Maria G. Tektonidou, Gkikas Katsifis, Athanasios Georgountzos, Athina Theodoridou, Eftychia-Maria Koukli, Anna Kandili, Giasna Giokic-Kakavouli, Theofilos-Diamantis Karatsourakis
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Objective: Our aim was to evaluate the effect of adalimumab on work productivity measures, overall activity impairment, and sleep quality in patients with active moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PsA), or ankylosing s
Externí odkaz:
https://doaj.org/article/5c7232a7e79b43f998e29fffa0fe1f36
Autor:
Karl Gaffney, Uta Kiltz, Petros Sfikakis, Nicola Gullick, Gkikas Katsifis, Anna Kandili, Jan Brandt-Juergens, Phillipe Goupille, Nicola Maiden, Maher Aassi, Barbara Schulz, Effie Pournara, Piotr Jagiello
Publikováno v:
Rheumatology. 61
Background/Aims Secukinumab has demonstrated long-lasting efficacy and a favorable safety profile in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). SERENA is an ongoing, longitudinal, observational study in > 2900 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b41469b14769cfe3973ad44718d0ef84
https://doi.org/10.1093/rheumatology/keac133.267
https://doi.org/10.1093/rheumatology/keac133.267
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 20:595-602
Objectives: This study looks deeper into the relationship between rheumatoid arthritis (RA) disease activity and distinct dimensions of sleep quality. Methods: The Pittsburgh Sleep Quality Index (P...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9073e3f195110a9cb88d9e6201b9605f
https://doi.org/10.1080/14737167.2020.1677156
https://doi.org/10.1080/14737167.2020.1677156
Autor:
Spilios Manolakopoulos, Hariklia Kranidioti, Xenophon Papacharalampous, Dimitrios Vassilopoulos, Anna Kandili, Dimitrios G. Pectasides
Publikováno v:
Mediterranean Journal of Rheumatology, Vol 27, Iss 2, Pp 40-47 (2016)
Background: Liver fibrosis is an infrequent complication of methotrexate (MTX) treatment diagnosed by liver biopsy, an invasive procedure rarely used in clinical practice. Objectives: To evaluate liver fibrosis by transient elastography (TE, FibroSca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c47a58cbf32e1e8cad4977c2178b65f
https://www.mjrheum.org/assets/files/792/file38_996.pdf
https://www.mjrheum.org/assets/files/792/file38_996.pdf
Autor:
Dimitrios Vassilopoulos, Varvara Podia, Emilia Hadziyannis, Stamatoula Tsikrika, Anna Kandili, Nikolaos Stamoulis, Chrisoula Hatzara
Publikováno v:
Clinical and Vaccine Immunology. 18:2102-2108
Gamma interferon release assays (IGRAs) are increasingly used for latentMycobacterium tuberculosisinfection (LTBI) screening in patients with rheumatic diseases starting anti-tumor necrosis factor (anti-TNF) therapies. We compared the performances of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45af95d85ba3c0df82cee6cd624722b0
https://doi.org/10.1128/cvi.05299-11
https://doi.org/10.1128/cvi.05299-11
Autor:
Anastasia Makris, Anna Kandili, Georgios Georgiopoulos, Emilia Hadziyannis, Chrisoula Hatzara, Dimitrios Vassilopoulos, Christos Koutsianas
Publikováno v:
Annals of the rheumatic diseases. 74(10)
To determine the rate of tuberculosis (TB) screening test conversion during anti-tumour necrosis factor (TNF) therapy in rheumatic patients with negative baseline screening.This was a prospective study of rheumatic patients with negative baseline TB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc370811ec650b4e1fbde00aaa713743
https://pubmed.ncbi.nlm.nih.gov/24854354
https://pubmed.ncbi.nlm.nih.gov/24854354
Autor:
Ioannnis Mitroulis, Chrisoula Hatzara, Anna Kandili, Emilia Hadziyannis, Dimitrios Vassilopoulos
Publikováno v:
Annals of the rheumatic diseases. 72(2)
Patients with rheumatic diseases and chronic, or less frequently, resolved hepatitis B virus (HBV) infection, can develop viral reactivation during antitumor necrosis factor therapy.1–3 Treatment with chemotherapeutic regimens that includes rituxim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b404954be12c8429842b4c9800d70056
https://pubmed.ncbi.nlm.nih.gov/22930597
https://pubmed.ncbi.nlm.nih.gov/22930597
Autor:
Christos Koutsianas, Anna Kandili, Katerina Antonatou, Konstantinos Thomas, Dimitrios Vassilopoulos, Chrisoula Hatzara, Christina Tsalapaki
Publikováno v:
Annals of the Rheumatic Diseases. 74:481.1-481
Background There are limited data to guide the selection of the first non-anti-TNF biologic DMARD (bDMARDs) after anti-TNF failure in rheumatoid arthritis (RA) patients. Objectives To evaluate the drug survival of non-anti-TNF IV bDMARDs in RA patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7e79c9b2406158a501bbf8074842afa
https://doi.org/10.1136/annrheumdis-2015-eular.5008
https://doi.org/10.1136/annrheumdis-2015-eular.5008
Autor:
C. Tsalapaki, E. Kyritsi, Dimitrios Vassilopoulos, Antonios Antoniadis, Chrisoula Hatzara, Anna Kandili
Publikováno v:
Annals of the Rheumatic Diseases. 71:658.11-658
Background Rheumatoid arthritis (RA) is associated with increased morbidity and mortality due to cardiovascular diseases. This association may be due to clustering of traditional cardiovascular risk factors among RA patients and/or to the chronic inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d273caaaba23252ad2711ba4bb0f2d6e
https://doi.org/10.1136/annrheumdis-2012-eular.364
https://doi.org/10.1136/annrheumdis-2012-eular.364
Autor:
Anna Kandili, Emilia Hadziyannis, Dimitrios Vassilopoulos, S. Tsikrika, M. Minopetrou, Chrisoula Hatzara, G. Georgiopoulos
Publikováno v:
Annals of the Rheumatic Diseases. 71:658.10-658
Background Despite negative baseline testing for tuberculosis (TB) with traditional (tuberculin skin test/TST, chest X-ray/CXR) or newer (interferon-gamma release assays/IGRAs) screening methods, a small number of patients receiving anti-tumor necros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::753f7c31dc63b2ce6980ffb598ee6693
https://doi.org/10.1136/annrheumdis-2012-eular.363
https://doi.org/10.1136/annrheumdis-2012-eular.363